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R21. Introduction
The anthracycline antibiotics, such as daunomycin (Daunobla-
stin) 1, doxorubicin (Adriablastin) 2 and semi-synthetic
idarubicin (Zavedos) 3 are a widely-studied class of chemo-
therapeutic agents currently used in the treatment of a broad
spectrum of solid tumours, lymphomas and leukaemias (Arca-
mone, 1981; Grynkiewicz et al., 2002; Monneret, 2001). Dau-35873435.
iller.com (J.P. Miller).
venue, Mayﬁeld, East Sussex
y. Production and hosting by
Saud University.
lsevier
ND license.nomycin 1 was originally isolated as a red-coloured
metabolite from cultures of Streptomyces peucetius (Cassinelli
and Orezzi, 1963). Although they are often used (as water sol-
uble hydrochloride salts) in combination with other agents,
they still present unpleasant side-effects (including cardio-tox-R1 O OH O
O
OH
NH2Me
1: R1=OMe, R2=H: Daunomycin
2: R1=OMe, R2=OH: Doxorubicin (Adriamycin)
3: R1=H, R2=H: Idarubicinicity and attack of the mucous membranes) and doxorubicin 2
activity can be impeded by the outgrowth of drug-resistant tu-
mours (Priebe et al., 1998; Robinson et al., 1997).
Their primary mode of interaction with tumour cells is by a
process of intercalation (Chaires, 1998) into the major groove
276 J.P. Miller, R.J. Stoodleyof nucleolar DNA and inhibition of the replication process
(Fig. 1 which also includes a spermine ligand based on Dautant
et al., 1995; key: carbon atom, grey; oxygen, red; nitrogen
blue). The DNA base pairs above and below the drug ‘buckle’
in conformation to afford a distorted DNA helix (Frederick
et al., 1990; Wang et al., 1987) thereby preventing correct asso-
ciation with the DNA helicase, topoisomerase II (Wang, 1996;
Pommier, 1995) and polymerase families of enzymes to initiate
DNA replication for RNA synthesis, protein formation and
thereby cell division.
Also, the anthracyclines can cause DNA single-strand
breaks by way of free radicals (Arcamone, 1981) and, there-
fore, cause irreversible damage. A few years ago, a group of
synthesised alkylcyclines was reported with both DNA alkylat-
ing and intercalating properties (Geroni et al., 2001).
It was decided to prepare the previously unknown ring-D
modiﬁed anthracycline 4 and to assess its anticancer activity
as a more bulky ring-D would make intercalation more difﬁ-
cult and could prove whether intercalation is necessary for tu-
mour growth inhibition. Indeed the more bulky bicyclic
nogalamycin 5 intercalates (Smith et al., 1995) into DNA cre-
ating a more strained complex and shows anticancer activity.
O
O
OH
OH
O
O
OH
O
OH
NH2Me
D C B A
4
O OH
N
Me
HO
Me
Me
OH
O
O OH
CO2Me
O
O
OH
Me
OMe
OMe
Me
Me
OMe
5
1
2
3
4
5 6
7
8
910
1112
Over the last several decades, syntheses of anthracyclinones
and anthracyclines have been developed, initially creating race-
mic mixtures (Arcamone, 1981) and then focusing on stereose-
lective routes to enantiomerically pure anthracyclinones
(Achmatowicz and Szechner, 2008).
Monosaccharides, such as D-glucose are used as chiral aux-
iliaries in organic synthesis (Tadano and Totani, 2008) and inFigure 1 Intercalation of idarubicin 3 with D(CGATCG)
fragment.this study it is attached to silyloxy dienes. Following Stood-
ley’s chromatography-free synthesis of (+)-4-dem-
ethoxydaunomycinone (the aglycone of idarubicin) (Gupta
et al., 1984), it was decided to follow a similar approach using
a D-glucose-based silyloxy diene, based upon the asymmetric
Diels–Alder reaction (Ban˜uelos et al., 2010; Nicolaou et al.,
2002; Whiting, 1996) as shown in Scheme 1. Here, the elec-
tron-deﬁcient oxirane 6 reacted with the electron-rich diene 7
to afford the cycloadduct 8 (60% diastereomeric excess) in
74% yield (Gupta et al., 1984). An analytical sample was ob-
tained after two crystallisations. Enantiopure syntheses of sev-
eral other anthracyclinones were subsequently reported
(Bourghli and Stoodley, 2004; Edwards et al., 1991; Kotha
and Stoodley, 2002) involving similar asymmetric Diels–Alder
reactions.
In this article based upon the Doctoral thesis (Miller, 1994),
part of the synthesis is reported directed towards the target
anthracycline 4 and the preparation of a new D-glucose-based
diene 21 and some of its chemistry investigated. The stereo-
chemistry of the new compounds described in this study is
from the model 14 described and by analogy to previously re-
ported investigations (Gupta et al., 1984, 1988).
2. Experimental (materials and methods)
Ethyl acetate and hexanes were distilled prior to use. Dry sol-
vents used in the experiments were prepared as follows: dichlo-
romethane was distilled off calcium hydride or phosphorus(v)
oxide and stored over 4A˚ molecular sieves; hexane was distilled
off phosphorus(v) oxide; benzene and toluene were distilled off
sodium benzophenone ketyl. Dry diethyl ether used for the tri-
tuations and crystallisations was prepared by allowing the sol-
vent to stand over sodium wire for a minimum of one week.
Deuteriochloroform, used as a solvent for the determination
of NMR spectra, was stored over tin granules. TLC (Thin
Layer Chromatography) was carried out on Merck plastic
plates coated with silica gel (60 F254). The plates were either
observed under UV light (Mineralight UVG2-58 lamp) or
developed with iodine vapour or a sulfuric acid stain (EtOH:
conc. H2SO4: p-MeOC6H4CHO, 95:4:1). Column chromatog-
raphy was performed under pressure (ca. 7 · 104 Pa) using
either Merck Kieselgel H Type 60 or Crossﬁeld Sorbsil C60
ﬂash silica. Melting points were determined using a Bu¨chi
512 melting point apparatus. Optical rotations, measured at
ca. 20 C using either a Thorn Type 243 or an Optical Activity
1000 polarimeter, are given in 101 deg cm2 g1. IR spectra
were recorded using a Perkin–Elmer 783 spectrometer using
KBr discs. A Perkin–Elmer Lambda 15 was used to determineO
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Scheme 1 Asymmetric Diels–Alder reaction.
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cm2 mmol1. 1H NMR spectra were measured at room tem-
perature at 300 MHz using a Brucker AC 300 or a 220 MHz
using a Perkin–Elmer spectrometer. A Kratos MS45 spectrom-
eter was used to obtain EI and CI mass spectra (NH3 as the
carrier gas); FAB mass spectra (p-NO2C6H4CH2OH as matrix)
were measured using a Kratos Concept IS spectrometer. Ele-
mental analyses were performed with a Carlo–Erba Model
1106 analyser.
2.1. Preparation of 1,4,4a,9a-tetrahydro-5,8-dihydroxy-1,4-
ethano-9,10-anthraquinone (11)
To a solution of naphthazarin 10 (1.9 g, 10 mmol) in toluene
(40 ml) cyclohexa-1,3-diene (2.43 g, 30.32 mmol) was added.
The mixture was heated at reﬂux under argon for 3 days. After
removal of the solvent and residual diene by evaporation, the
crude cycloadduct 11 (2.62 g, 9.69 mmol, 97%) was obtained.
Crystallisation from chloroform afforded the title compound
11 (1.67 g, 6.18 mmol, 62%) as a brown solid, m.p. 128–
132 C, IR(KBr): mmax (cm1): 1620 (C‚O) and 1580, kmax
(EtOH): 398 (e 7700), 232 (16 300) and 213 (13 600) nm; 1H
NMR(CDCl3, 300 MHz): dH: 1.41–1.48 and 1.77–1.84 (each
2 H, m, CH2CH2), 3.19 (2 H, s, 4a- and 9a-H), 3.42 (2 H, br
s, 1- and 4-H), 6.22 (2 H, dd, 3J 4.5, 3J 3 Hz, 2- and 3-H),
7.22 (2 H, s, 6- and 7-H) and 12.8 (2 H, s, 5- and 8-OH); EI-
MS: m/z: 270 (M+) 5% and 80, 100%; CI-MS: m/z: 271
(MH+) 100%. Anal. Calc. for C16H14O4: C, 71.1; H, 5.2.
Found: C, 71.2; H, 5.2%.
2.2. Preparation of 1,2,3,4,4a,9a-hexahydro-5,8-dihydroxy-1,4-
ethano-9,10-anthraquinone (12)
The cycloadduct 11 (0.305 g, 1.128 mmol) was stirred with
10% palladium on charcoal (0.15 g, 0.5 mass eq.) in dry
dichloromethane (10 ml) under an atmosphere of hydrogen
for 1 day (the reaction being monitored by 220 MHz 1H
NMR spectroscopy). After ﬁltration through celite and re-
moval of the solvent from the ﬁltrate, the crude reduced prod-
uct (0.28 g, 1.03 mmol, 91%) was obtained. Crystallisation
from 1:1 chloroform-hexane afforded an analytical sample of
title compound 12 (0.10 g, 0.367 mmol, 32.5%) as a light-yel-
low solid, m.p. 153-153.5 C, IR(KBr): mmax (cm1): 1610
(C‚O); kmax (EtOH): 398 (e 7400), 256 (9200), 233 (16 100)
and 212 (12 700) nm; 1H NMR(CDCl3, 300 MHz): dH: 1.45
and 1.75 (each 4 H, br s, together CH2CH2), 2.39 (2 H, br s,
1- and 4-H), 3.12 (2 H, s, 4a- and 9a-H), 7.29 (2 H, s, 7- and
8-H) and 12.77 (2 H, s, 5- and 8-OH); EI-MS: m/z: 272
(M+) 100% and 192, 92%; CI-MS: m/z: 273 (MH+) 100%
and 272 (M+) 36%. Anal. Calc. for C16H16O4: C, 70.6; 5.9.
Found: C, 70.9; H, 5.7%.
2.3. Preparation of 1,2,3,4-tetrahydro-5,8-dihydroxy-1,4-
ethano-9,10-anthraquinone (13)
A solution of compound 12 (4.28 g, 15.72 mmol) was warmed
with 5 M sodium hydroxide (500 ml) in the presence of air for
6 h (the process being followed by TLC). Acidiﬁcation at 0 C
with hydrochloric acid and ﬁltration afforded a red solid. After
washing with water and drying (P2O5; in vacuo), the quinol 13
was recovered (3.75 g, 13.87 mmol, 88%). An analytical sam-ple (2.94 g, 10.9 mmol, 69%) was obtained by crystallisation
from ethyl acetate to afford a red solid, m.p. 182–183 C,
IR(KBr): mmax (cm
1): 1610 (C‚O) and 1570 (C‚C); kmax
(EtOH): 549 (e 4800), 518 (6900), 287 (7900) and 217
(31 000) nm; 1H NMR(CDCl3, 300 MHz): dH: 1.35 and 1.81
(each 4 H, br d, separation 7 Hz, 2 · CH2CH2), 3.58 (2 H, br
s, 1- and 4-H), 7.20 (2 H, s, 6- and 7-H) and 12.73 (2 H, s,
5- and 8-OH); EI-MS: m/z: 270 (M+) 83% and 242 (M+
-C2H4) 100%; CI-MS: m/z: 273 (MH3
+) 100%. Anal. Calc.
for C16H14O4: C, 71.1; 5.2. Found: C, 70.8; H, 5.1%.2.4. Reaction of 1,2,3,4-tetrahydro-5,8-dihydroxy-1,4-ethano-
9,10-anthraquinone (13) with the D-glucose-based diene (14)
A solution of the quinol 13 (0.09 g, 0.333 mmol) and the D-glu-
cose-based diene 14 (Larsen and Stoodley, 1989) (0.36 g,
0.680 mmol) in ‘analar’ toluene (8 ml) was reﬂuxed under argon
for 2.5 days. Removal of the solvent afforded a red-brown solid
(0.46 g), which comprised of the cycloadduct 15 together with a
trace of compound 16 and the glycoside 18 from its 300 MHz 1H
NMRspectrum. Subjection of thismaterial to silica-gel chroma-
tography [hexane-ethyl acetate (8:1–2:1) as eluant] afforded
three fractions. The ﬁrst-eluted material (0.015 g, 0.033 mmol,
10%)was 1,2,3,4-tetrahydro-5,12-dihydroxy-9-tert-butyldimeth-
ylsilyloxy-1,4-ethanonaphthacene-6,11-dione (16), m.p. 191–
192 C, IR(KBr): mmax (cm1): 1750 and 1585 (C‚O); kmax
(EtOH): 518 (e 4800), 481 (7200), 268 (23 100), 232 (12 800),
214 (15 200) nm; 1H NMR(CDCl3, 300 MHz): dH: 0.31 (6 H,
s,Me2Si), 1.02 (9 H, s,Me3C), 1.39 and 1.85 (each 4H, br d, sep-
aration 7 Hz, 2 · CH2CH2), 3.70 (2 H, br s, 1- and 4-H), 7.20 (1
H, dd, 3J 8.5 Hz, 2.5 Hz, 8-H), 7.70 (1 H, d, 3J 2.5 Hz, 7-H), 8.24
(1 H, d, 3J 8.5 Hz, 10-H) and 13.35 & 13.52 (each 1 H, s, 5- and
12-OH); EI-MS: m/z: 450 (M+) 100%, 383 (M+–Me3C) 79%
and 338, 13%; CI-MS: (m/z): 451 (MH+) 100%; FAB-MS:
(m/z): 451 (MH+) 100%. Anal. Calc. for C26H30O5Si: C, 69.3;
H, 6.7; Si, 6.2. Found: C, 69.0; H, 6.8; Si, 5.9%.
The second-eluted material (0.133 g, approx. 50% of 15) was
crystallised from chloroform-hexane followed by dichlorometh-
ane-hexane to give (6aR,7S,10aR)-1,2,3,4,6a,7,10,10a-octahy-
dro-5,12-dihydroxy-7-(2’,3’,4’,6’-tetra-O-acetyl-b-D-glucopyr-
anosyloxy)-9-tert-butyldimethylsilyloxy-1,4-ethanonaphthacene-
6,11-dione (15) (0.062 g, 0.077 mmol, 23%) as a pale-yellow
solid,m.p. 179-180 oC, [a]D+281 (c 0.05%inCH2Cl2), IR(KBr):
mmax (cm
1): 1750 (ester C‚O) and 1670 (ketone C‚O); kmax
(EtOH): 517 (180), 484 (275), 396 (9400), 273 (7300), 243 (24
300) and 205 (19 200) nm; 1H NMR(CDCl3, 300 MHz): dH:
0.18 and 0.22 (each 3 H, s, Me2Si), 0.95 (9 H, s, Me3C), 1.29
and 1.47 (each 2 H, br d, separation 8 Hz, CH2CH2), 1.80 (4
H, br d, separation 9 Hz, CH2CH2), 1.73, 1.88, 1.97 and 2.09
(each 3 H, s, 4 ·MeCO2), 2.16 (1 H, dd, 3J 18.5 Hz, 3J 8 Hz,
10-H b), 3.1–3.2 (1 H, m, 6a-H), 3.38 (1 H, t, 3J 7 Hz, 10a-H),
3.52–3.58 (1 H, m, 50-H), 3.61-3.65 (each 1 H, br s, 1- and 4-H),
4.04 (1 H, dd, 3J 12 Hz, 3J 2.5 Hz, 60-H), 4.17 (1 H, dd, 3J
12 Hz, 3J 4.5 Hz, 60-H), 4.36-4.44 (2H, m, 10- and 20-H), 4.56
(1 H, t, 3J 5 Hz, 7-H), 4.94-4.96 (2 H, m, 30- and 40-H), 5.15
(1 H, d, 3J 4.5 Hz, 8-H), 11.66 and 12.28 (each 1 H, s, 5- and
12-OH)(irradiation at d 4.56 caused them at d 3.1-3.2 to simplify
and the d at d 5.15 to collapse to a s); FAB-MS: m/z: 800 (M+)
1.5%, 453 (M+–C14H19O10) 36% and 73, 100%. Anal. Calc.
for C40H52O15Si: C, 60.0; H, 6.6; Si, 3.5. Found: C, 59.2; H,
6.4; Si, 3.4%.
278 J.P. Miller, R.J. Stoodley(b) A stirred solution of the quinol 13 (0.486 g, 1.8 mmol)
and the D-glucose-based diene 14 (1.024 g, 1.93 mmol) in
‘analar’ toluene (30 ml) was heated at 98 C under argon.
The reaction was followed by 300 MHz 1H NMR spectros-
copy and, after 3 days, a further quantity of the diene
(0.30 g, 0.57 mmol) dissolved in ‘analar’ toluene (30 ml) was
added [to react with the unchanged quinol]. This mixture
was heated at 98 C for a further 24 h. Removal of the solvent
in vacuo afforded mainly a 3:1 mixture of a 60% d.e. of the
cycloadduct 15 and the quinol 13, together with a trace of
compound 16. Crystallisation of the mixture from diethyl
ether-hexane gave mainly the cycloadduct 15 (0.53 g,
0.66 mmol, 37%). Attempted recrystallisation of the impure
cycloadduct 15 from diethyl ether-hexane gave an oil, which
was subjected to silica-gel chromatography [hexane-EtOAc
(8:1–1:1) as eluant].
The ﬁrst eluted material (0.337 g) was observed as a
5.7:4:3.1 mixture of compounds 19, the C-9 ketone and 15.
Recrystallisation of this mixture from dichloromethane-hexane
afforded a mixture; its 300 MHz 1H NMR revealed that partial
hydrolysis (de-O-silylation) to the C-9 ketone had occurred. A
ﬁnal recrystallisation of this material afforded a yellow solid
(0.165 g, 0.21 mmol, 11%) which contained a 11:2 mixture of
(6aR,7S,10aR)-1,2,3,4,6a,7,8,10a-octahydro-5,12-dihydroxy-
(2’,3’,4’,6’-tetra-O-acetyl-b-D-glucopyranosyloxy)-9-tert-butyl-
dimethylsilyloxy-1,4-ethanonaphthacene-6,11-dione (19) and
the cycloadduct 15, m.p. 177.5–179 C, [a]D +231 (c 0.05%
in CH2Cl2), IR(KBr): mmax (cm
1): 1750 (C‚O); kmax (EtOH):
517 (e 5600), 483 (8800), 347 (10 100), 294 (4800), 274 (7500),
244 (25 800) and 205 (20 000) nm; for compound (19) 1H
NMR(CDCl3, 300 MHz): dH: 0.21 (6 H, s, Me2Si), 0.93 (9
H, s, Me3C), 1.31 and 1.38 (each 2 H, d,
3J 9 Hz, 3J 6.5 Hz,
2 · CH2CH2), 1.81 (4 H, d, 3J 6.5 Hz, CH2CH2), 1.58, 1.89,
1.97 and 2.09 (each 3 H, s, 4 ·MeCO2), 2.41–2.61 (2 H, m,
8-Ha and 8-Hb), 3.10 (1 H, dd, 3J 9 Hz, 3J 2 Hz, 6a-H),
3.54–3.60 (1 H, m, 50-H), 3.64–3.66 (3 H, m, 1-, 4- and 10a-
H), 4.05 (1 H, dd, 3J 12 Hz, 3J 2.5 Hz, 60-H), 4.19 (1 H, dd,
3J 12 Hz, 3J 5 Hz, 60-H), 4.41–4.47 (2 H, m, 7- and 10-H),
4.58 (1 H, m, 20-H), 4.94–4.97 (2 H, m, 30- and 40-H), 5.26 (1
H, dd, 3J 5 Hz, 3J 1.5 Hz, 10-H), 12.02 and 12.48 (each 1H,
s, 5- and 12-OH) (irradiation at d 3.10 caused the two br s at
d 3.6-3.64 to split into 3 signals and the m at d 4.44 to simplify;
irradiation of the m at d 3.58 caused the dd at d 4.02 and 4.18
to collapse to two d (3J 12 Hz) and the m at d 4.96 to simplify;
irradiation of the m at d 4.58 caused the m at d 4.41–4.47 and
4.96 to simplify; irradiation at d 5.26 caused the two br s at d
3.6–3.64 to split into three signals and a minor change in the
range d 2.45–2.61); FAB-MS: (m/z): 800 (M+) 18%, 743
(M+–Me3C) 1% and 453 (M
+–C14H19O10) 100%. Anal. Calc.
for C40H52O15Si: C, 60.0; H, 6.6; Si, 3.5. Found: C, 60.0; H,
6.6; Si, 3.6%.
(c) To a stirred solution of the quinol 13 (0.013 g,
0.048 mmol), was added the D-glucose-based diene 14
(0.039 g, 0.073 mmol) and Eu(fod)3 (0.002 g, 4 mol%) in
‘analar’ toluene (5 ml) and was heated at reﬂux under argon.
After 2 days, a further quantity of the diene (0.017 g,
0.032 mmol) was added. Thus, after 4 h, a 1:1.1:1:0.4 ratio
of compounds 13, 15, 14 and 16 was present; after 21 h, a
1:2.4:0.2:0.4 ratio of compounds 13, 15, 16 and 17 was de-
tected; after 3 days only the aromatic compound 16 and the
tetra-acetylglucose 17 were observed by 300 MHz 1H NMR
spectroscopy.2.5. Preparation of (E)-1-(20,30,40,60-tetra-O-acetyl-b-D-
glucopyranosyloxy)-3-triisopropylsilyloxybuta-1,3-diene (21)
To a solution of the glycoside 18 (2.50 g, 6 mmol) and trieth-
ylamine (2.1 ml, 15 mmol) in dry dichloromethane (30 ml)
was slowly added triisopropylsilyl triﬂate (3.75 g, 12.2 mmol)
at room temperature. An immediate darkening in colour was
observed. After 70 min, triethylamine (3 ml, 21 mmol) and
dichloromethane (30 ml) were added to the mixture, which
was subsequently diluted with water. The organic phase
was separated and washed with saturated aqueous sodium
hydrogen carbonate, dried (MgSO4) and evaporated to give
a yellow oil. Trituration with dry diethyl ether and hexanes
afforded the diene 21 (1.48 g, 2.58 mmol, 43%) as a cream
solid, m.p. 51-52 C, [a]D 15 (c 0.6% in EtOH), IR(KBr):
mmax (cm
1): 1760 (ester C‚O), 1655 and 1640 (C‚C); kmax
(EtOH) 240 (e 14,200) nm; 1H NMR(CDCl3, 300 MHz): dH:
1.10 (18 H, d, 3J 6.5 Hz, 3 ·Me2CH), 1.21 (3 H, apparent
heptet, separation 6.5 Hz, 3 · CHMe2), 2.01, 2.03, 2.05 and
2.08 (3 H, s, 4 ·MeCO2), 3.80 (ddd, 1 H, 3J 10 Hz, 3J
5 Hz, 3J 2 Hz, 50-H), 4.10-4.15 (3 H, m, 4-H2 and 60-H),
4.24 (1 H, dd, 3J 12.5 Hz, 3J 5 Hz, 60-H), 4.78 (1 H, d, 3J
7.5 Hz, 10-H), 5.11 (2 H, apparent t, separation 9.5 Hz, 20-
and 40-H), 5.24 (1 H, t, 3J 9.5 Hz, 30-H), 5.65 (1 H, d, 3J
12 Hz, 2-H) and 6.80 (1 H, d, 3J 12 Hz, 1-H) ppm; FAB-
MS: (m/z): 573 (MH+), 15%, 331 (C14H19O9
+) 76% and
169, 100%. Found: MH+, 573.2766. C27H44O11Si requires
m/z 573.2731.
2.6. Preparation of (1R,2R,3S)-3-(20304060-tetra-O-acetyl-b-D-
glucopyranosyloxy)-5-tri-isopropylsilyloxycyclohex-4-ene-1,2-
N-phenyldicarboximide (22)
A solution of the diene 21 (0.590 g, 1.03 mmol) and N-phenyl-
maleimide (0.174 g, 1.0 mmol) in dry benzene (5 ml) was left at
room temperature for 1 day. Evaporation of the solvent left a
residue, which, on the basis of 300 MHz 1H NMR spectros-
copy, comprised mainly an 85:15 mixture of the cycloadducts
22 and 24. Trituration of the mixture with diethyl ether affor-
ded the cycloadduct 22 (0.202 g, 0.26 mmol, 26%). An analyt-
ical sample was obtained by crystallisation from dry
dichloromethane-dry diethyl ether-hexanes to afford the cyc-
loadduct 22 (0.140 g, 0.18 mmol, 18%) as a pale-cream solid,
m.p. 194–195 C, [a]D +51 (c 0.3%, CH2Cl2), IR (KBr): mmax
(cm1): 1760 (ester C‚O), 1710 (imide C‚O) and 1650
(C‚C); kmax (EtOH) 202 (e 23 000) nm;
1H NMR(CDCl3,
300 MHz): dH: 1.09 (18 H, d,
3J 6.5 Hz, 3 ·Me2CH), 1.14–
1.30 (3 H, m, 3 · CHMe2), 1.53, 1.95, 2.00 and 2.08 (each 3
H, s, 4 ·MeCO2), 2.57 (1 H, dd, 3J 16 Hz, 3J 9.5 Hz, 6-Ha),
2.84 (1 H, dd, 3J 16 Hz, 3J 9 Hz, 3J 2.5 Hz, 6-Hb), 3.18 (1 H,
dd, 3J 10.5 Hz, 3J 5 Hz, 2-H), 3.38 (1 H, apparent q, separation
10 Hz, 1-H), 3.60-3.65 (1 H, m, 50-H), 4.03 (1 H, dd, 3J
12.5 Hz, 3J 2 Hz, 60-H), 4.20 (1 H, dd, 3J 12 Hz, 3J 5 Hz, 60-
H), 4.63 (1 H, d, 3J 8 Hz, 10-H), 4.76–4.83 (2 H, m, 20- and
3-H), 5.00 (1 H, t, 3J 9.5 Hz, 40-H), 5.12 (1 H, t, 3J 9.5 Hz,
30-H), 5.19 (1 H, dd, 3J 7 Hz, 3J 2 Hz, 4-H), 7.31-7.50 (5 H,
m, Ph) ppm; FAB-MS: m/z: 768 (MNa+) 4%, 746 (MH+),
2%, 703 (M+–C3H6), 7%, 702 (M
+–CHMe2) 10%, 398
(M+–C14H19O10
+) 100%, 331 (C14H19O9
+) 14% and 173,
49%. Anal. Calc. for C37H51NO13Si: C, 59.6; H, 6.9; N, 1.9.
Found: C, 59.3; H, 6.8; N, 1.9%.
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First of all the dienophile 13 was prepared as it is known that
three-ringed dienophiles of this type tautomerise (Krohn and
Tolkiehn, 1979) when undergoing the Diels–Alder reaction.
This, therefore, avoids the extra steps in the preparation of a
bicyclic oxirane analogue 20 of the dienophile 13 and removal
of the oxirane functionality later on in the synthesis.
The previously unreported dienophile 13 was synthesised
(Scheme 2) from commercially available naphthazarin 10
(Caygill et al., 2001) [see (Hout and Brassard, 1974; Lewis
and Paul, 1977) for a multi-gram synthesis of 10] in three steps
and observed as a dark red solid in high yield from 10. Its less
stable tautomer (unobserved in the spectroscopic data) is rep-
resented below (structure 13a).
O
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13 13a
OH
OH
OH
OH
O
O
We were now in a position to evaluate its reactivity with the
D-glucose based diene (TBS-ether; 14) (Larsen and Stoodley,
1989), which proved to be more stable at higher temperatures
than the diene 7.
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Different temperatures (from 0 C to 160 C) and solvents
for the Diels–Alder reaction were investigated. Reaction of
the quinol 13 with excess diene 14 in dry toluene at 98 C affor-
ded a 60% diastereomeric excess of the cycloadduct 15 after
several days; the minor diastereomer 15a detected in the 1HO
O
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+
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Scheme 2 Preparation of the dienophile 13.NMR spectrum of the mixture had the opposite conﬁguration
at C-6a, C-7 and C-10a. The presence of the minor diastereo-
mer of type 15a was predicted by way of comparison to a pre-
viously reported investigation (Scheme 1) (Gupta et al., 1984)
affording a 60% diastereomeric excess of cycloadduct 8 and by
comparing the heights of the integrals of the 5- and 12-OH
singlets of 15 and 15a, respectively. Subjection of this mixture
to silica-gel chromatography afforded the major diastereomer
15 (50% yield); an analytical sample (23% yield) was obtained
after crystallisation. This cycloadduct possessed satisfactory
spectroscopic data and use of the Karplus equation helped
to determine to conformation of the ring-A by conversion of
the vicinal coupling constants to torsional angles. Although
the cycloadduct 15 is formed by heating the quinol 13 with
the diene 14, it is unstable at the temperature of reﬂuxing tol-
uene and undergoes some decomposition to a red solid 16 [an
aromatic ring-A is created by elimination of the tetra acetyl-
glucose 17]. The diene 14 is unstable too and decomposes to
the glycoside 18.
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On a larger scale using similar reaction conditions, crystal-
lisation of the resultant mixture from dry ether-hexane gave
the crude cycloadduct 15 in approx. 37% yield based upon
the quinol 13. Further puriﬁcation of compound 15 by silica-
gel chromatography (ethyl acetate/hexane elution) and recrys-
tallisation (chloroform/hexane) led to isomerisation of the
double bond to positions 9,10 in ring-A, to afford predomi-
nantly the compound 19 (11% analytical yield) [11:2 mixture
of compounds 19:15].
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In these diastereoselective Diels–Alder reactions, the dieno-
phile tautomerises at elevated temperatures in order to allow
the pericyclic reaction to occur at the C-6 and C-7 positions;
no attachment of the diene at the C-4a and C-9a positions
occurred.
It was previously determined (Larsen and Stoodley, 1989)
that the D-glucose based diene of type 14 exists in different
conformations with regards to the diene moiety as based on
the exo-anomeric effect (Gupta et al., 1989) in which the O-1
280 J.P. Miller, R.J. Stoodley(between the diene and sugar) is sp2 hybridised and its p-orbi-
tal overlaps with the p* antibonding orbital of the diene moi-
ety and the r* antibonding orbital as a result of the bond
between C-10 and O-10 in 14a; when O-1 is SP3 hybridised (in
C-1, O-1 saturated systems) there is a more favourable gauche
(60) relationship. The major cycloadduct formed results from
endo top-side attack of the preferred conformation 14 by a die-
nophile, in the direction of the arrow, and the minor diastereo-
mer from below the conjugated double bond. Obviously, the
steric hindrance from the sugar reduces underside attack to
lead to an approximate 60% diastereomeric excess of the ma-
jor diastereomer.
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Clearly, using the quinol 13 as a dienophile avoids the
unnecessary steps in synthesising the analogous oxirane of type
20 and later removal of the oxirane moiety, despite its slow
reactivity and some thermal decomposition of the cycloadduct.
The inﬂuence of a small amount the Eu(fod)3 catalyst (Lowe
and Stoodley, 1994) (lanthanide shift reagent) upon the reac-
tion was studied under these conditions, on a very small scale,
following its course by 1H NMR spectroscopy. After 4 hours
an equal amount of quinol 13 and cycloadduct 15 were de-
tected; after 21 hours the ratio changed to 1:2.4, but unfortu-
nately after 3 days only the aromatic material 16 and the tetra-
acetylglucose 17 were detected. The minor diastereomer of
type 15a was not detected in the mixture, so it is possible that
the reaction was more diastereoselective and faster, but ulti-
mately of little practical use.
With a view to developing a more efﬁcient route, it was
decided to prepare the glucose-based diene 21. Hopefully it
would be less prone to decomposition than its relatives 7 or 14.
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21The glycoside 18 reacted with triisopropyl triﬂate (Corey
et al., 1981) in the presence of triethylamine to afford the
triisopropylsilyl-D-glucose-based diene 21 in 43% yield. The
diene 21 showed the expected spectroscopic properties, albeit
with a surprisingly low melting point.
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It was of interest to compare the reactivity and diastereofa-
cial selectivity of the dienes 7 and 21 with N-phenylmaleimide.
Thus, in benzene at room temperature, the diene 21 reacted
with N-phenylmaleimide to give predominantly a 85:15 mix-
ture of the cycloadducts 22 and 24 by 300 MHz 1H NMR spec-
troscopy, which after trituration with ether afforded the
cycloadduct 22 in 26% yield. Crystallisation produced an ana-
lytical sample in 18% yield. Previously, the diene 7 had been
shown (Gupta et al., 1988) to give a 86:14 mixture of the cyc-
loadducts 23 and 25 and to afford after trituration and crystal-
lisation the major compound 23 in 52% yield. Spectroscopic
and microanalytical data were consistent for the cycloadduct
22. Hydrolysis (de-O-silylation) of the cycloadduct 22 in acid-
iﬁed (0.1 M HCl) THF afforded (Miller, 1994) the C-5 ketone,
which is a known compound (Gupta et al., 1988). Unfortu-
nately, the reactivity of the diene 21 towards the quinol 13
was poor in toluene at 98 C even in the presence of Eu(fod)3.
Further steps towards the synthesis of the anthracycline 4 via
the de-O-silylated C-9 ketone have been previously reported
in the Doctoral thesis (Miller, 1994).
4. Conclusions
The D-glucose-based diene of type 14 has reacted with the no-
vel quinol 13 to afford a cycloadduct 15 (50%) with moder-
ately high diastereoselectivity although the cycloadduct 15
has been found to be unstable under certain conditions and
prone to thermolysis or isomerisation. Also, the previously
unreported D-glucose-based silyloxy diene 21 has been found
to undergo Diels–Alder reactions in a similar manner to the
known dienes 7 and 14 and could be used in synthesis. D-glu-
cose-based silyloxy dienes can also be unstable upon heating
(e.g., 98 C) for prolonged periods during a reaction.Acknowledgements
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